These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20520552)

  • 21. Psoriatic arthritis: a review.
    Amherd-Hoekstra A; Näher H; Lorenz HM; Enk AH
    J Dtsch Dermatol Ges; 2010 May; 8(5):332-9. PubMed ID: 20015187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-TNF-alpha treatment and spondyloarthropathies].
    Braun Y; Balbir-Gurman A
    Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
    Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
    Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of psoriatic arthritis with biological agents.
    Ceponis A; Kavanaugh A
    Semin Cutan Med Surg; 2010 Mar; 29(1):56-62. PubMed ID: 20430309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case report.
    Lamazza L; Guerra F; Pezza M; Messina AM; Galluccio A; Spink M; De Biase A
    Aust Dent J; 2009 Jun; 54(2):161-5. PubMed ID: 19473159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.
    Valleala H; Korpela M; Möttönen T; Hienonen-Kempas T; Kauppi M; Hannonen P; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(5):323-7. PubMed ID: 19585384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study.
    Yee CS; Filer A; Pace A; Douglas K; Situnayake D; Rowe IF;
    Rheumatology (Oxford); 2003 Jul; 42(7):856-9. PubMed ID: 12730544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of psoriatic arthritis.
    Sharma A; Dogra S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):645-51. PubMed ID: 21079307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
    Smith JR; Levinson RD; Holland GN; Jabs DA; Robinson MR; Whitcup SM; Rosenbaum JT
    Arthritis Rheum; 2001 Jun; 45(3):252-7. PubMed ID: 11409666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
    Tse SM; Burgos-Vargas R; Laxer RM
    Arthritis Rheum; 2005 Jul; 52(7):2103-8. PubMed ID: 15986366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
    Nash P; Clegg DO
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of psoriatic arthritis.
    Balakrishnan C; Madnani N
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S18-24. PubMed ID: 23974691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era.
    Gladman DD; Ziouzina O; Thavaneswaran A; Chandran V
    J Rheumatol; 2013 Aug; 40(8):1357-9. PubMed ID: 23818708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.
    Caso F; Lubrano E; Del Puente A; Caso P; Peluso R; Foglia F; Benigno C; Girolimetto N; Bottiglieri P; Scarpa R; Costa L
    Expert Rev Clin Immunol; 2016; 12(3):315-31. PubMed ID: 26558483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease.
    Marchesoni A; Altomare G; Matucci-Cerinic M; Balato N; Olivieri I; Salvarani C; Lotti T; Scarpa R; Vena GA; Valesini G; Giannetti A
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):578-86. PubMed ID: 19874430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
    Coates LC; Kavanaugh A; Mease PJ; Soriano ER; Laura Acosta-Felquer M; Armstrong AW; Bautista-Molano W; Boehncke WH; Campbell W; Cauli A; Espinoza LR; FitzGerald O; Gladman DD; Gottlieb A; Helliwell PS; Husni ME; Love TJ; Lubrano E; McHugh N; Nash P; Ogdie A; Orbai AM; Parkinson A; O'Sullivan D; Rosen CF; Schwartzman S; Siegel EL; Toloza S; Tuong W; Ritchlin CT
    Arthritis Rheumatol; 2016 May; 68(5):1060-71. PubMed ID: 26749174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of psoriatic arthritis].
    Märker-Hermann E
    Z Rheumatol; 2013 Oct; 72(8):784-90. PubMed ID: 24043297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.